HTG Molecular Diagnostics, Inc. (HTGMQ)

0,0025 0,0000 (0,00%) Al cierre: 03:55PM EDT

HTG Molecular Diagnostics, Inc.

3430 East Global Loop
Tucson, AZ 85706
United States
877 289 2615
https://www.htgmolecular.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 53

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. John L. Lubniewski	President, CEO & Director	821,19k	N/A	1964
Mr. Shaun D. McMeans	Senior VP, CFO, Secretary & Treasurer	533,97k	N/A	1962
Ms. Laura Lee Godlewski	Senior Vice President of Finance & Administration	N/A	N/A	1980
Dr. Debra A. Gordon	Senior VP & Chief Legal Counsel	219,47k	N/A	1960
Dr. Patrick C. Roche	Senior Vice President of Research & Development	257,58k	N/A	1953
Dr. Stephen A. Barat Ph.D.	Senior Vice President of Therapeutics	N/A	N/A	1970
Dr. Christina M. Carruthers Ph.D.	Vice President of Target Strategy & Early Development	N/A	N/A	N/A
Debrah Thompson	Vice President of Scientific Innovation	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Gobierno corporativo

El ISS Governance QualityScore de HTG Molecular Diagnostics, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.